MyoKardia's mission is to revolutionize the treatment of genetic cardiomyopathies and related heart disease through exploiting advances in sarcomere-related biochemistry and molecular biology.
MyoKardia is developing a pipeline of novel, small molecule therapeutics that address key clinical needs for patients with genetic heart disease.
Learn More